CATEGORY
ISPOR
- ABPI
- ACE
- ACIS
- Adelaide
- Aetsa
- Agenas
- AHRQ
- AIFA
- AMNOG
- ANVISA
- AOTMiT
- AQuAS
- Behandlingsraadet
- BfArM
- Biocat
- C2H
- CADTH
- CDC
- CDE
- CMS
- COFEPRIS
- CONITEC
- Digemid
- EFPIA
- EMA
- EPF
- Eucope
- EUnetHTA
- EuropaBio
- European Commission
- Euskadi
- FDA
- FOPH
- G-BA
- Gesundheit Österreich
- HAS
- Health Technology Wales
- Healthcare Improvement Scotland
- HHS
- HIQA
- HTAi
- ICER
- IECS
- IETS
- IHE
- IHEA
- INAHTA
- IQWiG
- ISPOR
- KCE
- Medicaid
- Medicines for Europe
- MHRA
- MSP
- NECA
- NHS
- nHTA
- NICE
- NIH
- NIHO
- NIHR
- NIPH
- NSW Health
- NZa
- OHE
- OYS
- PBS
- pCPA
- Pharmac
- PhRMA
- Salute
- SBU
- Schönermark Kielhorn Collegen
- SGK
- TÄ°TCK
- TLV
- WHO
- ZonMw
- Zorginstituut Nederland
ISPOR Debuts HEOR Explained to Enhance Healthcare Decision-Making
Maximizing Efficiency in Healthcare Innovation: The Transformative Role of NICE Advice
HEOR Scientists Bolster Healthcare Evidence Amid Biopharma Shifts
ISPOR Publishes Best Practices for Expert Elicitation in Healthcare Decision-Making
COPD Experience Measure Translated and Validated for Catalan and Spanish Patients
ISPOR Celebrates Leaders in Health Economics with 2024 Awards
Medicare’s Strategy for Drug Price Negotiations Uncovered
ISPOR Europe 2024 Plenaries and Speakers Announced
ISPOR Unveils Ambitious Strategic Plan 2030 to Transform Global Healthcare
Shaping the Future of Health and Well-Being Through Evidence Generation
Methods for Comparing Uncontrolled Trials with Real-World Data
ISPOR and ACCESS Forum Announce Strategic Collaboration for Upcoming Conferences in Barcelona
Strategic Plan Unveiled for ISPOR’s Strategic Vision 2030
ISPOR Examines Quality-Adjusted Life Years and Alternatives in Healthcare Decision-Making
Health Technology Assessments Enhanced by ISPOR’s New SUITABILITY Checklist for EHR Data